The first International Forum on Cell and Gene Therapy was successfully held. Professor Shi Yuanyuan, deputy director of Cell Medicine Branch & Chairman of Shenzhen Cell Valley, and his team appeared
The First International Forum on Cell Gene Therapy and the Second Forum on the Development of New Vaccines and Biological Products
On the morning of November 15th, the opening ceremony of the "Two Sessions" was held in Conference Hall 2 of Shenzhen International Convention and Exhibition Center. They shared the latest research results and profound insights in the field of cellular gene therapy.
Professor Shi Yuanyuan, Vice Chairman of the Cell Medicine Branch and Chairman of Shenzhen Cell Valley, presided over the opening ceremony and group standard release ceremony of the forum as Co Executive Chairma
Under the careful preparation and leadership of Professor Chen Junhui, co executive chairman of the forum and Peking University Shenzhen Hospital, the conference was successfully held. Professor Chen briefly introduced the organizational structure and situation of the "Two Sessions". The forum has one main forum and six sub forums, with a total of over 1500 participants. It is a large-scale, highly professional, and widely influential professional technical competition.
Professor Lu Jiahai, Co Executive Chairman of the Forum and Director of the Key Laboratory for Quality Monitoring and uation of Vaccines and Biological Products
Mao Zhenbin, Academician of the United Nations International Academy of Sciences for Ecological Life Safety and President of the China Food and Drug Safety Promotion Association
Liu Xuejun, Director of the Healthcare Professional Committee of the China Economic System Reform Research Association
Professor Jiang Yuyang, Deputy Director of the Standing Committee of the Shenzhen Municipal People's Congress, held a national group standard release ceremony. In order to promote the internationalization of cell gene therapy in China and fill the industry gap, the forum released the "Preparation and Application Specification for Cell Gene Therapy". Qingdao Haier Biotechnology Co., Ltd. and Peking University Shenzhen Hospital led the "External System Testing of Human Mesenchymal Stem Cells". And the "Guidelines for the Development of (Cellular) Immunotherapy Products Based on mRNA LNP Technology" led by the Key Laboratory of Quality Monitoring and uation of Vaccines and Biological Products and Hunan Yuantai Biotechnology Co., Ltd. It is of great and far-reaching significance to break through the key technological bottlenecks that currently constrain the development of the industry, seize the high ground of the new round of technological and industrial revolution, and promote the industry towards high-end development. High quality development.
Group photo of attendees and representatives of leadership units
Forum: Frontiers in Biomedical Innovation
Chairman of the Expert Committee of the Branch of Cell Medicine, Professor Wu Zhihong of Peking Union Medical College Hospital, Professor Wan Xiaochun of the Chinese Academy of Sciences Shenzhen Institute of Advanced Technology, National Respiratory Diseases????
Professor Xianen Zhang, Professor of School of Synthetic Biology, Shenzhen University of Technology, Academician of American Academy of Medical and Biological Engineering -- "Synthetic Biology Enables New Quality Productivity"
Academician Mao Zhenbin, President of the China Food and Drug Safety Promotion Association - "Regulatory Science Promotes Innovative Development of Advanced Medical Products"
Prof. Jiang Jianli replaces Prof. Chen Zhinan, Academician of Chinese Academy of Engineering and Professor of Air Force Medical University -- "International Trends in Biomedical Technology and Bioeconomy
Dr. Ruhong Jiang, Chairman of ASC Therapeutics, represented Professor Mark A Kay, a member of the National Academy of Inventors
Professor Wang Jianjun, Frontier Cross Center, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences
At the main forum, five top experts with a reputation in the field of biomedicine made in-depth speeches and exchanges around the theme of "Frontier Innovation in biomedicine". From different perspectives, they shared their latest research results, innovative ideas and future development trends in the field of biomedicine. Through the wonderful speeches of the above experts, the participants were able to gain insight into the latest developments in the field of biomedicine, and also inspired everyone to think deeply about scientific and technological innovation and industrial development.
Sub-forum: Cell Preparation and Carrier Technology Forum
On the afternoon of November 15, the cell preparation and carrier technology Forum was held as scheduled. The forum was kicked off by Professor Shi Yuanyuan, chairman of Shenzhen Cell Valley, and Dr. Xiang Hua, co-founder and deputy general manager of Shenzhen Cell Valley, and conducted in-depth discussions and exchanges on the latest progress and future development direction of cell preparation and carrier technology.
Professor Wang Jianxun, chief scientist of Shenzhen Cell Valley, was invited to attend the forum and share academic information on "Progress in Cell immunotherapy Research". With his profound atments in the field of immunology, Professor Wang Jianxun had an in-depth discussion with the experts and scholars attending the meeting, and jointly explored the latest trend of technological innovation and industry development of cellular immunotherapy. In addition, the forum was honored to bring together Academician Zhang Dan, co-chairman of Jiangsu Puxin Biomedicine Company, and other experts and scholars in the field of cellular immunotherapy
China Food and Drug Safety Promotion Association excellent member enterprises high-tech achievements exhibition
The 26th China International High-tech Fair (CHTF) was successfully concluded on November 16, 2024. Among them, in the biomedical sector, the cell and gene therapy and vaccine Forum and the high-tech achievements exhibition of excellent member enterprises became a highlight of the fair, and the exhibition attracted more than 15,000 visitors to visit and negotiate business during the three days.
As an excellent enterprise in the field of cell and gene therapy, Shenzhen Cell Valley was invited to attend the exhibition. During the exhibition, Shenzhen Cell Valley was highly concerned by the academicians and leaders of the tour. Chairman Professor Shi Yuanyuan introduced the core advantages and business scope of Shenzhen Cell Valley to them in detail. As the only one-stop solution provider for cell and gene therapy that can provide industrial-grade retroviral vector in China, Shenzhen Cell Valley has built a standardized, standardized and industrial production of GMP grade retroviral vector (RVV) and CAR-T cell product pipelines, which can provide products from virus vector pipelines to cell product pipelines. To the IIT/IND/NDA auxiliary declaration and industry personnel training, etc., has established a mature whole process, one-stop entrusted service.
Chairman Professor Shi Yuanyuan took a group photo with the traveling academicians and leaders
This event provided a stage for Shenzhen Cell Valley to show its strength, exchange and cooperation to relevant fields and internationally, and fully demonstrated the development prospects of Shenzhen Cell Valley in the field of cell and gene therapy. Shenzhen Cell Valley will take this event as an opportunity to further accelerate the pace of its own technological innovation and market expansion, help the rapid development of the cell and gene therapy industry, and contribute more to improving the level of human health.
